Coexistence of Standard Modifiable, Other Classical, and Novel and Classical Atherosclerotic Cardiovascular Disease Risk Factors in Middle Eastern Young Women

References

• Gusev E, Sarapultsev A. Atherosclerosis and inflammation: insights from the theory of general pathological processes. Int J Mol Sci. 2023;24(9):1.
   Web of Science ®Google Scholar
• Jebari-Benslaiman S, Galicia-García U, Larrea-Sebal A, et al. Pathophysiology of atherosclerosis. Int J Mol Sci. 2022;23(6):3346. doi:10.3390/ijms23063346
   PubMed Web of Science ®Google Scholar
• Wolf D, Ley K. Immunity and inflammation in atherosclerosis. Circulat Res. 2019;124(2):315–327. doi:10.1161/CIRCRESAHA.118.313591
   PubMed Web of Science ®Google Scholar
• Chiorescu RM, Mocan M, Inceu AI, Buda AP, Blendea D, Vlaicu SI. Vulnerable atherosclerotic plaque: is there a molecular signature? Int J Mol Sci. 2022;23(21):13638. doi:10.3390/ijms232113638
   PubMed Web of Science ®Google Scholar
• Barquera S, Pedroza-Tobias A, Medina C, et al. Global overview of the epidemiology of atherosclerotic cardiovascular disease. Archiv Med Res. 2015;2015:46.
   Google Scholar
• Arnett DK, Blumenthal RS, Albert MA, et al. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the American college of cardiology/American heart association task force on clinical practice guidelines. Circulation. 2019;140(11):e596–e646. doi:10.1161/CIR.0000000000000678
   PubMed Web of Science ®Google Scholar
• Wong ND, Budoff MJ, Ferdinand K, et al. Atherosclerotic cardiovascular disease risk assessment: an American society for preventive cardiology clinical practice statement. Am J Prevent Cardiol. 2022;10:100335.
   PubMedGoogle Scholar
• Bays HE, Taub PR, Epstein E, et al. Ten things to know about ten cardiovascular disease risk factors. Am J Prevent Cardiol. 2021;5:100149. doi:10.1016/j.ajpc.2021.100149
   PubMedGoogle Scholar
• Powell-Wiley TM, Baumer Y, Baah FO, et al. Social Determinants of Cardiovascular Disease. Circulat Res. 2022;130(5):782–799. doi:10.1161/CIRCRESAHA.121.319811
   PubMed Web of Science ®Google Scholar
• Braveman P, Gottlieb L. The social determinants of health: It’s time to consider the causes of the causes. Public Health Rep. 2014;129(Suppl 2):19–31. doi:10.1177/00333549141291S206
   PubMed Web of Science ®Google Scholar
• O’Kelly AC, Michos ED, Shufelt CL, et al. Pregnancy and reproductive risk factors for cardiovascular disease in women. Circulat Res. 2022;130(4):652–672. doi:10.1161/CIRCRESAHA.121.319895
   PubMed Web of Science ®Google Scholar
• Mehta LS, Velarde GP, Lewey J, et al. Cardiovascular disease risk factors in women: the impact of race and ethnicity: a scientific statement from the American heart association. Circulation. 2023;147(19):1471–1487. doi:10.1161/CIR.0000000000001139
   PubMed Web of Science ®Google Scholar
• Shawky NM. Cardiovascular disease risk in offspring of polycystic ovary syndrome. Front Endocrinol. 2022;13:977819. doi:10.3389/fendo.2022.977819
   PubMed Web of Science ®Google Scholar
• Mehta PK, Gaignard S, Schwartz A, Manson JE. Traditional and emerging sex-specific risk factors for cardiovascular disease in women. RCM. 2022;23(8):1.
   Google Scholar
• Sarraju A, Spencer-Bonilla G, Chung S, et al. Statin use in older adults for primary cardiovascular disease prevention across a spectrum of cardiovascular risk. J Gen Intern Med. 2022;37(11):2642–2649. doi:10.1007/s11606-021-07107-7
   PubMed Web of Science ®Google Scholar
• Ding YQ, Yang SC, Lyu J, Li LM. [A review on cardiovascular disease risk prediction models in the elderly]. Zhonghua liu xing bing xue za zhi. 2023;44(6):1013–1020. Chinese. doi:10.3760/cma.j.cn112338-20221104-00940
   PubMedGoogle Scholar
• Balla S, Gomez SE, Rodriguez F. Disparities in cardiovascular care and outcomes for women from racial/ethnic minority backgrounds. Curr Treat Options Cardiovasc Med. 2020;22(12):75. doi:10.1007/s11936-020-00869-z
   PubMed Web of Science ®Google Scholar
• Velarde G, Bravo-Jaimes K, Brandt EJ, et al. Locking the revolving door: racial disparities in cardiovascular disease. J Am Heart Assoc. 2023;12(8):e025271. doi:10.1161/JAHA.122.025271
   PubMed Web of Science ®Google Scholar
• Roth GA, Mensah GA, Johnson CO, et al. Global burden of cardiovascular diseases and risk factors, 1990–2019: update from the GBD 2019 study. J Am Coll Cardiol. 2020;76(25):2982–3021. doi:10.1016/j.jacc.2020.11.010
   PubMed Web of Science ®Google Scholar
• Hammoudeh AJ, Alhaddad IA, Khader Y, et al. Cardiovascular risk factors in Middle Eastern patients undergoing percutaneous coronary intervention: Results from the first Jordanian percutaneous coronary intervention study. J Saudi Heart Assoc. 2017;29(3):195–202. doi:10.1016/j.jsha.2016.10.002
   PubMedGoogle Scholar
• Al-Shamsi S. Development and validation of a novel 10-year cardiovascular risk prediction nomogram for the United Arab Emirates national population. BMJ open. 2022;12(12):e064502. doi:10.1136/bmjopen-2022-064502
   PubMed Web of Science ®Google Scholar
• Raal FJ, Alsheikh-Ali AA, Omar MI, et al. Cardiovascular risk factor burden in Africa and the middle east across country income categories: a post hoc analysis of the cross-sectional Africa Middle East Cardiovascular Epidemiological (ACE) study. Arch Public Health. 2018;76(1):15. doi:10.1186/s13690-018-0257-5
   PubMedGoogle Scholar
• Hammoudeh A, Al-Tarawneh H, Elharassis A, et al. Prevalence of conventional risk factors in Jordanians with coronary heart disease: the Jordan Hyperlipidemia And Related Targets Study (JoHARTS). Int J Cardiol. 2006;110:179–183. doi:10.1016/j.ijcard.2005.08.005
   PubMed Web of Science ®Google Scholar
• Motlagh B, O’Donnell M, Yusuf S. Prevalence of cardiovascular risk factors in the Middle East: a systematic review. Europ J Cardiovasc Preven Rehabilit. 2009;16:268–280. doi:10.1097/HJR.0b013e328322ca1b
   PubMedGoogle Scholar
• Ramahi T. Cardiovascular disease in the Asia middle East region: global trends and local implications. Asia-Pacif J Pub Health. 2010;22:83S–89S. doi:10.1177/1010539510373034
   PubMed Web of Science ®Google Scholar
• Yu X, Chen L, Ding H, Zhao Y, Feng J. Iron transport from ferrous bisglycinate and ferrous sulfate in DMT1-knockout human intestinal caco-2 cells. Nutrients. 2019;11(3). doi:10.3390/nu11030485
   Web of Science ®Google Scholar
• Taylor CN, Wang D, Larson MG, et al. Family history of modifiable risk factors and association with future cardiovascular disease. J Am Heart Assoc. 2023;12(6):e027881. doi:10.1161/JAHA.122.027881
   PubMed Web of Science ®Google Scholar